RxDoctor Payments Data

Harsh Govil, MD

Interventional Pain Medicine · Statesville, NCNPI 1568671782

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (51.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 39 manufacturers reported payments, led by Milestone Scientific Inc. at 51.5% of the total. 2025 is the largest year on record at $12,088, 7.6 times the $1,593 reported in 2019.

$19,423in general payments, 2019–2025

Across 227 payments — averaging $85.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Milestone Scientific Inc.$10K
  • Boston Scientific$3K
  • Medtronic$2K
  • Curonix LLC$594
  • Si-bone, Inc.$558
  • Nevro Corp.$498
  • plus $3K from 33 others

What the payments were for

  • Consulting fees$10,00051%
  • Travel & lodging$1,4738%
  • Food & beverage$7,93041%
  • Education$200%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,423 in reported general payments places this provider in the 85th percentile of 45 interventional pain medicine providers in North Carolina.

See all interventional pain medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$288,941
Medicare patients
351
Services billed
10,915

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen86$944
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen33$627
Pregabalin30$333
Gabapentin20$171
Tramadol Hcl37$138
Prednisone17$93
Lorazepam34$13

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Statesville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →